EVALUATING VACCINATION EFFECTIVENESS OF GROUP-SPECIFIC FRACTIONAL-DOSE STRATEGIES

被引:0
|
作者
Chen, Zhimin [1 ,2 ]
Liu, Kaihui [3 ]
Liu, Xiuxiang [2 ]
机构
[1] Guangdong Polytech Normal Univ, Sch Math & Syst Sci, Guangzhou 510665, Peoples R China
[2] South China Normal Univ, Sch Math Sci, Guangzhou 510631, Peoples R China
[3] Jiangsu Univ, Fac Sci, Zhenjiang 212013, Jiangsu, Peoples R China
来源
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B | 2022年 / 27卷 / 02期
关键词
multi-group epidemic model; fractional-dose vaccines; group-specific vaccination; the final size; INACTIVATED POLIOVIRUS VACCINE; YELLOW-FEVER VACCINE; FINAL SIZE; INFLUENZA; EPIDEMIC; IMMUNOGENICITY; SAFETY; MODEL;
D O I
10.3934/dcdsb.2021062
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
In this paper, we formulate a multi-group SIR epidemic model with the consideration of proportionate mixing patterns between groups and group-specific fractional-dose vaccination to evaluate the effects of fractionated dosing strategies on disease control and prevention in a heterogeneously mixing population. The basic reproduction number R-0, the final size of the epidemic, and the infection attack rate are used as three measures of population-level implications of fractionated dosing programs. Theoretically, we identify the basic reproduction number, R-0, establish the existence and uniqueness of the final size and the final size relation with R-0, and obtain explicit calculation expressions of the infection attack rate for each group and the whole population. Furthermore, the simulation results suggest that dose fractionation policies take positive effects in lowering the R-0, decreasing the final size and reducing the infection attack rate only when the fractional-dose influenza vaccine efficacy is high enough rather than just similar to standard-dose. We find evidences that fractional-dose vaccination in response to influenza vaccine shortages take negative community-level effects. Our results indicate that the role of fractional dose vaccines should not be overestimated even though fractional dosing strategies could extend the vaccine coverage.
引用
收藏
页码:717 / 748
页数:32
相关论文
共 9 条
  • [1] Modelling epidemics with fractional-dose vaccination in response to limited vaccine supply
    Chen, Zhimin
    Liu, Kaihui
    Liu, Xiuxiang
    Lou, Yijun
    JOURNAL OF THEORETICAL BIOLOGY, 2020, 486
  • [2] Fractional-dose yellow fever vaccination: an expert review
    Roukens, Anna H. E.
    Visser, Leo G.
    JOURNAL OF TRAVEL MEDICINE, 2019, 26 (06)
  • [3] Fractional-dose yellow fever vaccination: how much more can we do with less?
    Visser, Leonardus G.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (05) : 390 - 393
  • [4] Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats
    Ma, Yan
    Ying, Zhifang
    Li, Jingyan
    Gu, Qin
    Wang, Xiaoyu
    Cai, Lukui
    Shi, Li
    Sun, Mingbo
    BIOLOGICALS, 2022, 75 : 3 - 11
  • [5] Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine
    Mvundura, Mercy
    Hsu, Jui-Shan
    Frivold, Collrane
    Kristensen, Debra
    Boyle, Shanda
    Zehrung, Darin
    Jarrahian, Courtney
    VACCINE: X, 2019, 2
  • [6] Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study
    Doshi, Reena H.
    Mukadi, Patrick K.
    Casey, Rebecca M.
    Kizito, Gabriel M.
    Gao, Hongjiang
    Nguete, U. Beatrice
    Laven, Janeen
    Sabi, Lilliane
    Kaba, Didine K.
    Muyembe-Tamfum, Jean-Jacques
    Hyde, Terri B.
    Ahuka-Mundeke, Steve
    Staples, J. Erin
    LANCET INFECTIOUS DISEASES, 2024, 24 (06) : 611 - 618
  • [7] Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trial
    Mottram, Lynda
    Lundgren, Anna
    Svennerholm, Ann-Mari
    Leach, Susannah
    VACCINE, 2020, 38 (03) : 655 - 662
  • [8] A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge
    Moon, James E.
    Greenleaf, Melissa E.
    Regules, Jason A.
    Debois, Muriel
    Duncan, Elizabeth H.
    Sedegah, Martha
    Chuang, Ilin
    Lee, Cynthia K.
    Sikaffy, April K.
    Garver, Lindsey S.
    Ivinson, Karen
    Angov, Evelina
    Morelle, Danielle
    Lievens, Marc
    Ockenhouse, Christian F.
    Ngauy, Viseth
    Ofori-Anyinam, Opokua
    VACCINE, 2021, 39 (43) : 6398 - 6406
  • [9] The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)
    Willem, Lander
    Abrams, Steven
    Franco, Nicolas
    Coletti, Pietro
    Libin, Pieter J. K.
    Wambua, James
    Couvreur, Simon
    Andre, Emmanuel
    Wenseleers, Tom
    Mao, Zhuxin
    Torneri, Andrea
    Faes, Christel
    Beutels, Philippe
    Hens, Niel
    BMC PUBLIC HEALTH, 2024, 24 (01)